By combining integrated-bioinformatics screening of clinically relevant PCa datasets with in vivo and in vitro molecular biology assays, we have recently described the metastasis suppressor activity of peroxisome proliferator-activated receptor γ (PPARγ) coactivator alpha (PGC1α)14,15. This evidence concerns the gene PPARGC1A and posterior cortical atrophy.